Pharmacogenomic Profiling in Personalized Therapeutics: Predicting Drug Response in High-Risk Patients with Cardiometabolic Disorders. (2025). International Journal of Health and Medical Research, 1(01), 28-37. https://research-education.com/index.php/ijhmr/article/view/6